Trajectories of persisting Covid- 19 symptoms up to 24 months after acute infection: findings from the Predi-Covid cohort study

Aurélie Fischer, Lu Zhang, Abir Elbéji, et. al.BMC Infectious Diseases volume 25, Article number: 603 (2025)  Abstract Introduction Long COVID is a multisystemic, fluctuating condition inducing a high burden on affected people. Despite the existence of some guidelines,…[...]

Read More

Polymyositis and Severe Rhabdomyolysis in the Context of Influenza and COVID-19 Vaccination: A Case Report

Angela Ghiletchi • Rodrigo Leão • Carolina Coelho, et. al., DOI: 10.7759/cureus.66957  Abstract Rhabdomyolysis is characterized by muscle breakdown and the release of muscle enzymes into the bloodstream, which can lead to acute kidney injury…[...]

Read More

Exploring DNA methylation, telomere length, mitochondrial DNA, and immune function in patients with Long-COVID

Andrea Polli, Lode Godderis, Dries S. Martens, et. al., BMC Medicine volume 23, Article number: 60 (2025)  Abstract Background Long-COVID is defined as the persistency or development of new symptoms 3 months after the initial SARS-CoV-2 infection, with…[...]

Read More

Exploring the landscape of long COVID: prevalence and associated factors in patients assisted by a telehealth service

Ana Flávia Avelar Maia Seixas, Milena Soriano Marcolino, Felipe Souza Guimarães, et. al.,, BMC Infectious Diseases volume 25, Article number: 509 (2025)  Abstract Introduction Long COVID is a condition that occurs in patients with a previous history of…[...]

Read More